AREG and colorectal carcinoma: This group examined AREG and EREG expression by real-time quantitative RT-PCR (TaqMan) in FFPE tumour primary CRC tissue from patients with irinotecan-resistant metastatic CRC treated with cetuximab and irinotecan and correlated expression with response and survival.